Reuters logo
BRIEF-EU approves Pfizer’s Trumenba to help prevent meningococcal group B disease in adolescents and adults
2017年5月30日 / 下午2点17分 / 6 个月前

BRIEF-EU approves Pfizer’s Trumenba to help prevent meningococcal group B disease in adolescents and adults

May 30 (Reuters) - Pfizer Inc

* European commission approves pfizer’s trumenba® to help prevent meningococcal group b disease in adolescents and adults

* Pfizer inc says trumenba approved in europe with option for a two- or three-dose schedule Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below